Cogent Biosciences, Inc.
- COGT
- NASDAQ
- Biotechnology
- Precision Oncology
- Kinase Inhibitors
$29.52
Today +0.03%Quote Oct 16, 2026, 08:00 PM UTC
−11.06%over the last month
Max drawdown −15.4%From 1-month high −11.1%3 months −22.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.12B
Quote Oct 16
Next earnings
Nov 6
Expected, not confirmed
Analyst target
$51.75
+75.3% from here
Floor
$29.34
0.6% below price
Where the price sits
12 analysts
Analyst range, low to high
$45.00$55.00
- Price $29.52
- Resistance $30.35
- Consensus $51.75
The price is just above its floor and right under resistance. Analysts' average target sits about 75% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COGTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
258